Top Markets
Coin of the day
Liminal BioSciences Inc. Liminal BioSciences Inc.

Liminal BioSciences Inc.

LMNL
Rankning i aktier #38952
Liminal BioSciences Inc. operates as a clinical-stage biopharmaceutical firm,... Liminal BioSciences Inc. operates as a clinical-stage biopharmaceutical firm, primarily engaged in creating innovative small molecule drug therapies. The company concentrates on addressing inflammatory, fibrotic, and metabolic diseases, with its operations spanning Canada and the United Kingdom. Its flagship drug candidate, fezagepras (identified as PBI-4050), has successfully advanced through Phase I clinical trials. This agent, along with its related derivatives, is undergoing investigation for potential application in treating idiopathic fibrosis affecting the lungs, liver, heart, or skin, as well as various respiratory conditions. Furthermore, Liminal is advancing antagonist programs, including G-protein coupled receptor 84 (GPR84) and Oxo-eicosanoid receptor 1 (OXER1), both of which are currently in preclinical development. Formerly known as Prometic Life Sciences Inc., the company adopted the name Liminal BioSciences Inc. in October 2019. Established in 1994, its corporate headquarters are located in Laval, Canada.
Aktiekurs
$8.50
Senast synkroniserad: 2023-09-26
Marknadsvärde
$719.10K
Förändring (1 dag)
0.00%
Förändring (1 år)
0.00%
Land
CA
Handel Liminal BioSciences Inc. (LMNL)

Kategori

Aktiekurshistorik för Liminal BioSciences Inc. (LMNL)
Högsta slutkurs: $8.45 den 2023-09-01

Lägsta slutkurs: $1.69K den 2009-12-01
Aktiekurshistorik för Liminal BioSciences Inc. från 2009 till 2026
Årlig aktiekursutveckling
År Prestanda
2023 112.62%
2022 -61.46%
2021 -76.57%
2020 -35.75%
2019 -97.45%
2018 -73.89%
2017 -28.49%
2016 -38.09%
2015 36.88%
2014 102.93%
2013 334.33%
2012 40.83%
2011 23.59%
2010 -34.41%
2009 0.00%
Aktiekurs för liknande företag eller konkurrenter
Företag Aktiekurs Förändring 1år% Land
$504.83 29.34%
US
$839.07 28.61%
NL
$728.83 6.71%
CH
$1.07K -6.40%
KR
$252.06 11.35%
BE